FISCHER vs GUJTHEM: Stock Comparison
GUJARAT THEMIS BIOSYN is the larger company by market capitalisation. FISCHER MEDICAL VENTURE L shows faster revenue growth and lower leverage, while GUJARAT THEMIS BIOSYN shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
FISCHER leads 3; GUJTHEM leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | FISCHER | GUJTHEM |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Medical Equipment & Supplies | Pharmaceuticals |
Price
| Metric | FISCHER | GUJTHEM |
|---|---|---|
| Live Price | ₹28.27 | ₹358.65 |
| Day Change | -4.69% | -3.95% |
| Volume | 4.1 L | 89,208 |
| 52-Week High | ₹121.7 | ₹479 |
| 52-Week Low | ₹29.11 | ₹225.05 |
| Distance from 52W High | -76.77% | -25.13% |
Valuation
| Metric | FISCHER | GUJTHEM |
|---|---|---|
| Market Cap | ₹1,846 Cr | ₹4,666 Cr |
| P/E Ratio | 61.33x | 0x |
| P/B Ratio | 4.81x | 0x |
| EPS | ₹0.06 | ₹1.02 |
| Book Value | ₹5.88 | ₹26.41 |
| Dividend Yield | 0.18% | 0.19% |
Growth
| Metric | FISCHER | GUJTHEM |
|---|---|---|
| Revenue Growth (TTM YoY) | 98.7% | 17.2% |
| EPS Growth (TTM YoY) | 0% | -9.1% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | FISCHER | GUJTHEM |
|---|---|---|
| ROE | 8.05% | 16.22% |
| ROCE | 7.89% | 11.12% |
| Net Margin | 6.79% | 28.15% |
| Operating Margin | 16.99% | 39.22% |
| Debt to Equity | 0.19x | 0.56x |
Shareholding
As of Aug 2026 • change vs previous quarter| Metric | FISCHER | GUJTHEM |
|---|---|---|
| Promoter Holding | 12.31%▲ 0.85 pp | 70.86% |
| FII Holding | 5.57%▲ 0.09 pp | 1.77%▼ 0.03 pp |
| DII Holding | 1.26%▼ 0.09 pp | 1.18% |
| Public Holding | 30.09%▼ 0.93 pp | 26.19%▲ 0.03 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FISCHER MEDICAL VENTURE L and GUJARAT THEMIS BIOSYN.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.